SCHEMBL8043906

SCHEMBL8043906

CCN(CC)c1n[nH]c2nc(-c3cnn4ccc(OC)cc34)c(F)cc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 3/20 0.35
WDR77 Q9BQA1 3/20 0.35
PIK3CA P42336 1/20 0.35
CRHR1 P34998 3/20 0.35
AMY1A P0DUB6 1/20 0.34
HTR2C P28335 2/20 0.33
HTR2A P28223 1/20 0.33
ALDH1A1 P00352 4/20 0.33
PRKAB2 O43741 1/20 0.33
PRKAG1 P54619 1/20 0.33
PRKAA2 P54646 1/20 0.33
PRKAA1 Q13131 1/20 0.33
PRKAG3 Q9UGI9 1/20 0.33
PRKAG2 Q9UGJ0 1/20 0.33
PRKAB1 Q9Y478 1/20 0.33
KDM4E B2RXH2 4/20 0.32
PKM P14618 1/20 0.32
EPHB3 P54753 1/20 0.32
TGFBR2 P37173 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8054838 0.90 PIK3CA (0.36) PRMT5WDR77PIK3CAAMY1AALDH1A1
SCHEMBL8041870 0.87 PIK3CA (0.34) PRMT5WDR77PIK3CAAMY1AHTR2C
SCHEMBL8043913 0.86 PIK3CA (0.36) PRMT5WDR77PIK3CAAMY1AHTR2C
SCHEMBL13099768 0.85 PRMT5 (0.37) PRMT5WDR77
SCHEMBL3243059 0.84 PRMT5 (0.36) PRMT5WDR77PIK3CAHTR2CHTR2A
SCHEMBL13099740 0.84 IGF1R (0.35) PRMT5WDR77PIK3CAALDH1A1PRKAB2
SCHEMBL13099765 0.81 EGFR (0.37) PIK3CAALDH1A1KDM4EMAPK1
SCHEMBL13099739 0.81 EPHB3 (0.39) PIK3CAALDH1A1PRKAB2PRKAG1PRKAA2
SCHEMBL8049607 0.80 PDE2A (0.39) PRMT5WDR77PIK3CAALDH1A1KDM4E
SCHEMBL8047356 0.79 MAP4K1 (0.38) HTR2CHTR2AMAPK1PDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100256133-A1 NOVEL COMPOUNDS HAVING INDAZOLE FRAMEWORKS, METHODS FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHOONGWAE PHARMA CORPORATION (KR) 2010-10-07 US disclosed
US-20100256133-A1 NOVEL COMPOUNDS HAVING INDAZOLE FRAMEWORKS, METHODS FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHOONGWAE PHARMA CORPORATION (KR) 2010-10-07 US disclosed
WO-2009038385-A2 NOVEL COMPOUNDS HAVING INDAZOLE FRAMEWORKS, METHODS FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHOONGWAE PHARMA CORPORATION (KR) 2009-03-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256133-A1 NOVEL COMPOUNDS HAVING INDAZOLE FRAMEWORKS, METHODS FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME MAP3K20, MAP3K3, MAP3K1 PRMT5 692/4885WDR77 2472/4885PIK3CA 167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.